• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利：CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法，用中文像聊天一样搜索，搜遍4000万医学文献。AI智能推荐，让科研检索更轻松。

立即免费搜索

文件翻译

保留排版，准确专业，支持PDF/Word/PPT等文件格式，支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述，25分钟生成高质量综述，智能提取关键信息，辅助科研写作。

立即免费体验

Developing the evidence for evidence-based practice.

作者信息

Rush A John

机构信息

Department of Clinical Sciences, The University of Texas Southwestern Medical Center at Dallas, Dallas, Tex 75390-9066, USA.

出版信息

CMAJ. 2008 May 6;178(10):1313-5. doi: 10.1503/cmaj.080202.

DOI:10.1503/cmaj.080202
PMID:18458263
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC2335183/
Abstract
摘要

相似文献

1
Developing the evidence for evidence-based practice.为循证实践提供证据
CMAJ. 2008 May 6;178(10):1313-5. doi: 10.1503/cmaj.080202.
2
Pulse clomipramine for depressed adolescents.用氯米帕明脉冲治疗青少年抑郁症。
Am J Psychiatry. 1998 Jul;155(7):995. doi: 10.1176/ajp.155.7.995.
3
The failure of evidence-based medicine to guide treatment of antidepressant nonresponders.循证医学在指导抗抑郁药无反应者治疗方面的失败。
J Clin Psychiatry. 2006 Dec;67(12):1833-5. doi: 10.4088/jcp.v67n1202.
4
Clinical practice guidelines for depression in young people.青少年抑郁症临床实践指南。
Med J Aust. 2003 Mar 17;178(6):300; author reply 300-2. doi: 10.5694/j.1326-5377.2003.tb05205.x.
5
Can the placebo be the cure?
Science. 1999 Apr 9;284(5412):238-40. doi: 10.1126/science.284.5412.238.
6
Depression-free days as a summary measure of the temporal pattern of response and remission in the treatment of major depression: a comparison of venlafaxine, selective serotonin reuptake inhibitors, and placebo.无抑郁天数作为重度抑郁症治疗中反应和缓解时间模式的汇总指标：文拉法辛、选择性5-羟色胺再摄取抑制剂与安慰剂的比较
J Clin Psychiatry. 2003 Mar;64(3):321-30. doi: 10.4088/jcp.v64n0315.
7
Are paroxetine, fluoxetine, and sertraline equally effective for depression?帕罗西汀、氟西汀和舍曲林治疗抑郁症的效果相同吗？
J Fam Pract. 2002 Mar;51(3):285.
8
Venlafaxine versus sertraline for major depressive disorder.文拉法辛与舍曲林治疗重度抑郁症的比较。
J Clin Psychiatry. 2000 Nov;61(11):873-4. doi: 10.4088/jcp.v61n1111c.
9
Selective serotonin reuptake inhibitors: placebo washouts inflate antidepressant effects in general practice.选择性5-羟色胺再摄取抑制剂：在全科医疗中，安慰剂洗脱期夸大了抗抑郁药的疗效。
BMJ. 2005 Feb 19;330(7488):420. doi: 10.1136/bmj.330.7488.420-a.
10
[Relativising the significance of the results of metaanalyses: comments on the metaanalysis by Kirsch et al. 2008 regarding the effectiveness of modern antidepressants].[对荟萃分析结果的重要性进行相对化考量：对Kirsch等人2008年关于现代抗抑郁药疗效的荟萃分析的评论]
MMW Fortschr Med. 2009 Mar 26;151(13):80-3.

引用本文的文献

1
Circulating microRNA associated with future relapse status in major depressive disorder.与重度抑郁症未来复发状态相关的循环微RNA
Front Psychiatry. 2022 Aug 17;13:937360. doi: 10.3389/fpsyt.2022.937360. eCollection 2022.
2
Bringing a research base to psychiatry.为精神病学引入研究基础。
CMAJ. 2008 May 6;178(10):1257-60. doi: 10.1503/cmaj.080530.

本文引用的文献

1
Selective serotonin reuptake inhibitors for unipolar depression: a systematic review of classic long-term randomized controlled trials.用于单相抑郁症的选择性5-羟色胺再摄取抑制剂：经典长期随机对照试验的系统评价
CMAJ. 2008 May 6;178(10):1293-301. doi: 10.1503/cmaj.071068.
2
The meaning of translational research and why it matters.转化研究的意义及其重要性。
JAMA. 2008 Jan 9;299(2):211-3. doi: 10.1001/jama.2007.26.
3
Maximizing the adequacy of medication treatment in controlled trials and clinical practice: STAR(*)D measurement-based care.在对照试验和临床实践中最大化药物治疗的充分性：STAR(*)D基于测量的照护
Neuropsychopharmacology. 2007 Dec;32(12):2479-89. doi: 10.1038/sj.npp.1301390. Epub 2007 Apr 4.
4
Acute and longer-term outcomes in depressed outpatients requiring one or several treatment steps: a STAR*D report.需要一个或多个治疗步骤的抑郁症门诊患者的急性和长期转归：STAR*D报告
Am J Psychiatry. 2006 Nov;163(11):1905-17. doi: 10.1176/ajp.2006.163.11.1905.
5
Moderators of treatment outcomes: clinical, research, and policy importance.治疗结果的调节因素：临床、研究及政策重要性
JAMA. 2006 Sep 13;296(10):1286-9. doi: 10.1001/jama.296.10.1286.
6
Tranylcypromine versus venlafaxine plus mirtazapine following three failed antidepressant medication trials for depression: a STAR*D report.对于抑郁症，在三次抗抑郁药物试验失败后，反苯环丙胺与文拉法辛加米氮平的比较：一项STAR*D报告。
Am J Psychiatry. 2006 Sep;163(9):1531-41; quiz 1666. doi: 10.1176/ajp.2006.163.9.1531.
7
A comparison of lithium and T(3) augmentation following two failed medication treatments for depression: a STAR*D report.抑郁症两种药物治疗失败后锂盐与T(3)增效治疗的比较：一项STAR*D报告
Am J Psychiatry. 2006 Sep;163(9):1519-30; quiz 1665. doi: 10.1176/ajp.2006.163.9.1519.
8
A comparison of mirtazapine and nortriptyline following two consecutive failed medication treatments for depressed outpatients: a STAR*D report.米氮平与去甲替林对门诊抑郁症患者连续两次药物治疗失败后的疗效比较：一项STAR*D报告
Am J Psychiatry. 2006 Jul;163(7):1161-72. doi: 10.1176/ajp.2006.163.7.1161.
9
Report by the ACNP Task Force on response and remission in major depressive disorder.美国神经精神药理学院（ACNP）关于重度抑郁症反应与缓解的特别工作组报告。
Neuropsychopharmacology. 2006 Sep;31(9):1841-53. doi: 10.1038/sj.npp.1301131. Epub 2006 Jun 21.
10
Medication augmentation after the failure of SSRIs for depression.5-羟色胺再摄取抑制剂治疗抑郁症失败后的药物增效治疗。
N Engl J Med. 2006 Mar 23;354(12):1243-52. doi: 10.1056/NEJMoa052964.